Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA)

Jwan Khal, Michael J. Tisdale

Research output: Contribution to journalArticle

Abstract

Eicosapentaenoic acid (EPA) has been shown to attenuate muscle atrophy in cancer, starvation and hyperthermia by downregulating the increased expression of the ubiquitin-proteasome proteolytic pathway leading to a reduction in protein degradation. In the current study EPA (0.5 g/kg) administered to septic mice completely attenuated the increased protein degradation in skeletal muscle by preventing the increase in both gene expression and protein concentration of the alpha- and beta-subunits of the 20S proteasome, as well as functional activity of the proteasome, as measured by the 'chymotrypsin-like' enzyme activity. These results suggest that muscle protein catabolism in sepsis is mediated by the same intracellular signalling pathways as found in other catabolic conditions.
LanguageEnglish
Pages238-240
Number of pages3
JournalBiochemical and Biophysical Research Communications
Volume375
Issue number2
Early online date12 Aug 2008
DOIs
Publication statusPublished - 17 Oct 2008

Fingerprint

Eicosapentaenoic Acid
Muscle Proteins
Proteasome Endopeptidase Complex
Proteolysis
Sepsis
Down-Regulation
Degradation
Muscle
Proteins
Muscular Atrophy
Enzyme activity
Ubiquitin
Starvation
Gene expression
Skeletal Muscle
Fever
Gene Expression
Neoplasms

Keywords

  • sepsis
  • muscle atrophy
  • EPA
  • ubiquitin-proteasome proteolysis

Cite this

@article{17bc2e7b233c404ab8bff3f541287ac6,
title = "Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA)",
abstract = "Eicosapentaenoic acid (EPA) has been shown to attenuate muscle atrophy in cancer, starvation and hyperthermia by downregulating the increased expression of the ubiquitin-proteasome proteolytic pathway leading to a reduction in protein degradation. In the current study EPA (0.5 g/kg) administered to septic mice completely attenuated the increased protein degradation in skeletal muscle by preventing the increase in both gene expression and protein concentration of the alpha- and beta-subunits of the 20S proteasome, as well as functional activity of the proteasome, as measured by the 'chymotrypsin-like' enzyme activity. These results suggest that muscle protein catabolism in sepsis is mediated by the same intracellular signalling pathways as found in other catabolic conditions.",
keywords = "sepsis, muscle atrophy, EPA, ubiquitin-proteasome proteolysis",
author = "Jwan Khal and Tisdale, {Michael J.}",
year = "2008",
month = "10",
day = "17",
doi = "10.1016/j.bbrc.2008.08.004",
language = "English",
volume = "375",
pages = "238--240",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA). / Khal, Jwan; Tisdale, Michael J.

In: Biochemical and Biophysical Research Communications, Vol. 375, No. 2, 17.10.2008, p. 238-240.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA)

AU - Khal, Jwan

AU - Tisdale, Michael J.

PY - 2008/10/17

Y1 - 2008/10/17

N2 - Eicosapentaenoic acid (EPA) has been shown to attenuate muscle atrophy in cancer, starvation and hyperthermia by downregulating the increased expression of the ubiquitin-proteasome proteolytic pathway leading to a reduction in protein degradation. In the current study EPA (0.5 g/kg) administered to septic mice completely attenuated the increased protein degradation in skeletal muscle by preventing the increase in both gene expression and protein concentration of the alpha- and beta-subunits of the 20S proteasome, as well as functional activity of the proteasome, as measured by the 'chymotrypsin-like' enzyme activity. These results suggest that muscle protein catabolism in sepsis is mediated by the same intracellular signalling pathways as found in other catabolic conditions.

AB - Eicosapentaenoic acid (EPA) has been shown to attenuate muscle atrophy in cancer, starvation and hyperthermia by downregulating the increased expression of the ubiquitin-proteasome proteolytic pathway leading to a reduction in protein degradation. In the current study EPA (0.5 g/kg) administered to septic mice completely attenuated the increased protein degradation in skeletal muscle by preventing the increase in both gene expression and protein concentration of the alpha- and beta-subunits of the 20S proteasome, as well as functional activity of the proteasome, as measured by the 'chymotrypsin-like' enzyme activity. These results suggest that muscle protein catabolism in sepsis is mediated by the same intracellular signalling pathways as found in other catabolic conditions.

KW - sepsis

KW - muscle atrophy

KW - EPA

KW - ubiquitin-proteasome proteolysis

UR - http://www.scopus.com/inward/record.url?scp=50249171122&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2008.08.004

DO - 10.1016/j.bbrc.2008.08.004

M3 - Article

VL - 375

SP - 238

EP - 240

JO - Biochemical and Biophysical Research Communications

T2 - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -